The COVID-19 Clinical Research Coalition which will consist of physicians is targeting African and Asian countries with the poor health system.
A group of scientists and policymakers have launched an
international research campaign that will focus on COVID-19 treatments options
and vaccine research for low-income countries.
The COVID-19 Clinical Research Coalition which will consist of
physicians is targeting African and Asian countries with the poor health system.
The coalition will be headed by the Drugs for Neglected Diseases
Initiative-DNDI. The coalition brings together researchers from different
countries like the US, Switzerland, UK, Sweden, Kenya, Ethiopia and even
Uganda. According to DNDI, so far 70 collaborators have joined the coalition.
Several research trials are already underway in different parts of the world.
One of the largest that has been formed is the WHO Solidarity trial.
According to DNDI, unlike other big research coalitions that have
already been set up by the World Health Organisation, during the coalition
emphasis will be put on low-income countries, unlike other efforts.
The coalition will facilitate a coordinated approach so that all data from all
regions can be collected similarly, pooled and shared in real-time. This will
help countries and the WHO to make rapid evidence-based decisions on policies
The launch of the coalition comes at a time when COVID-19 is
spreading across the continent.
Dr Soumya Swaminathna, Chief Scientist, World Health Organization
says the coalition will create solutions for how Africa can handle the
“Although the epicentre is today elsewhere, we must prepare now for the
consequences of this pandemic in more resource-constrained settings or we stand
to lose many more lives,” he said.
According to Dr Swaminathna, the coalition will help WHO coordinate its global
response to COVID-19. The WHO Solidarity trial that was launched last month
mainly has Western countries involved.